Technical Analysis for OBIO - Orchestra BioMed Holdings, Inc.

Grade Last Price % Change Price Change
C 6.89 9.02% 0.57
OBIO closed up 9.02 percent on Monday, June 24, 2024, on approximately normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down

Date Alert Name Type % Chg
Boomer Sell Setup Bearish Swing Setup 0.00%
Crossed Above 200 DMA Bullish 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
20 DMA Resistance Bearish 9.02%
200 DMA Resistance Bearish 9.02%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 9.02%
Pocket Pivot Bullish Swing Setup 9.02%
Inside Day Range Contraction 9.02%
Wide Bands Range Expansion 9.02%

   Recent Intraday Alerts

Alert Time
Down 1% about 18 hours ago
Rose Above 200 DMA 4 days ago
20 DMA Resistance 4 days ago
2x Volume Pace 4 days ago
1.5x Volume Pace 4 days ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Orchestra BioMed, Inc. operates as a therapeutic device company that develops therapeutic treatments and products for cardiovascular diseases. It offers BackBeat Cardiac Neuromodulation Therapy (CNT), a patented, intelligent bioelectronic treatment for hypertension; Virtue SAB, a patented drug/device combination product for the treatment of artery disease; FreeHold Retractors, a minimally invasive surgical device solution; and Virtue SEB, a drug-eluting balloon angioplasty system for the treatment of coronary artery disease. Orchestra BioMed, Inc. has a strategic collaboration with Medtronic to develop BackBeat CNT as a potential treatment for hypertension in patients who are indicated for a cardiac pacemaker. The company was incorporated in 2017 and is based in New Hope, Pennsylvania.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Hypertension Cardiovascular Disease Neuromodulation Artery Disease Coronary Artery Disease Angioplasty Medtronic

Is OBIO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 11.68
52 Week Low 4.22
Average Volume 65,505
200-Day Moving Average 6.53
50-Day Moving Average 5.81
20-Day Moving Average 7.30
10-Day Moving Average 7.43
Average True Range 0.72
RSI (14) 51.22
ADX 39.73
+DI 14.16
-DI 22.10
Chandelier Exit (Long, 3 ATRs) 6.13
Chandelier Exit (Short, 3 ATRs) 7.01
Upper Bollinger Bands 8.86
Lower Bollinger Band 5.74
Percent B (%b) 0.37
BandWidth 42.68
MACD Line 0.32
MACD Signal Line 0.55
MACD Histogram -0.2253
Fundamentals Value
Market Cap 246.28 Million
Num Shares 35.7 Million
EPS -0.91
Price-to-Earnings (P/E) Ratio -7.57
Price-to-Sales 71.27
Price-to-Book 3.12
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.26
Resistance 3 (R3) 8.18 7.66 8.03
Resistance 2 (R2) 7.66 7.31 7.69 7.95
Resistance 1 (R1) 7.27 7.09 7.47 7.35 7.88
Pivot Point 6.75 6.75 6.84 6.78 6.75
Support 1 (S1) 6.36 6.40 6.56 6.44 5.90
Support 2 (S2) 5.84 6.18 5.87 5.83
Support 3 (S3) 5.45 5.84 5.75
Support 4 (S4) 5.53